#38: Pill Panic: Glenmark Capsules Recalled in the US

• 🚽 Loo-gical insights, literally! Kohler’s new smart toilet sensor peeks into your poop to track hydration, gut health, and blood traces. (TheVerge)

• 🔎 Seeing the impossible! PRIMA, a new tiny electronic eye implant, helps people with incurable blindness regain partial vision. (TheGuardian)

• 👁️ The FDA approved Glaukos’ incision-free therapy for keratoconus (cone-shaped cornea), offering patients a safer, more comfortable treatment expected to launch in early 2026. (Reuters)

• 💡 U.S. health-tech giant Optum is using AI to settle claims in record time; connecting payers and providers in real-time for clearer coverage, cleaner claims, and faster patient insights. (HealthcareIT)

• 🌿 From pantry staples to potent healers! Nagaland University identifies sinapic acid in mustard and citrus as a promising agent for diabetic wound recovery. (ETHealth)

• 💉U.S.-based Janssen Pharmaceuticals’ precision injection, Rybrevant, targets head & neck cancer, shrinking tumours in just 6 weeks with a 76% success rate in global trials. (TheGuardian)

• 💊 Antidepressants can change your weight, too: UK study shows some cause gain, others loss; personalised treatment is key. (TheGuardian)

• 💊 India’s first indigenous antibiotic Nafithromycin is here, fighting stubborn respiratory infections in just 3 days, especially in immunocompromised patients. (TribuneIndia)

• 🔥Eli Lilly and Cipla are launching Yurpeak in India, a weekly injection for diabetes and weight loss. The goal: wider access at prices similar to Mounjaro. (ET)

• 🚨 Oops, Glenmark’s birth control pills hit a snag! 26,000 India-made packs recalled in the US after failing FDA impurity checks. Class II recall: risky, but not life-threatening. (ET) 

• ❄️ Chill out, menopause! Bayer’s Lynkuet gets FDA approval for a non-hormonal pill to tackle severe hot flashes, hitting the U.S. pharmacies this November. (CNN)

🇮🇳 India

• 🛑 ORS or sugar shock? The Delhi High Court has permitted the sale of existing stocks of banned ORSL fruity drinks worth around ₹180Cr, until the FSSAI completes its hearing. (TheHindu)

• ⛑️ Healthcare on the line! Kerala ASHA health workers strike for higher pay and post-retirement benefits, face police detentions, as leaders call for urgent dialogue. (TNM)

• ⚖️ SC has issued a notice to Fortis Hospital in a medical negligence case dating back to 2017, in which an 8-year-old allegedly suffered a birth-related brain injury. (ETHealth)

• 🌴 Big news from the Malabar coast! The World Bank approved $280M to revamp Kerala’s health sector - boosting elderly care and supercharging digital health. (ETHealth)

🌏️ Global

• 💉 Polio on pause? A $1.7B funding shortfall could stall global eradication efforts warns WHO, urging donors to step up before progress reverses. (Aljazeera)

• ♀️The NHS is adding menopause to routine checks, meaning midlife mystery symptoms like memory fog and joint aches might finally get an actual diagnosis. (BBC)

• 👴🏻 Historic move! Uruguay legalises euthanasia, letting terminally ill adults request a dignified death, the first in Latin America. (ST)

🇮🇳 India

• 🏥 ICICI Bank joins the fight against cancer! After NSE funded ₹380 Cr, ICICI is donating ₹625 Cr for an 11-storey facility at Tata Memorial Center, set to serve 7,200+ patients annually. (ETHealth) (ETHealthWorld)

🌏️ Global

• 💰 Pharma Boom! Following AstraZeneca’s $4.5B plant in the U.S., Merck kicks off a $3B manufacturing hub in Virginia, as part of its $70B U.S. investment spree. (Reuters) 

• 📱 Samsung Electronics acquires U.S.-based digital health platform Xealth, which allows doctors to prescribe and track health apps directly from EHRs. (MobiHealthNews)

📢 Enjoyed this edition? Forward it to a friend or colleague who’d love to stay informed! They can subscribe here.